These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38168683)

  • 1. Polymyxin B and ethylenediaminetetraacetic acid act synergistically against
    Hale SJM; Cameron AJ; Lux CA; Biswas K; Kim R; O'Carroll M; Harris PWR; Douglas RG; Wagner Mackenzie B
    Microbiol Spectr; 2024 Feb; 12(2):e0170923. PubMed ID: 38168683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
    Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
    ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
    Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
    ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiofilm Activities of Borneol-Citral-Loaded Pickering Emulsions against Pseudomonas aeruginosa and Staphylococcus aureus in Physiologically Relevant Chronic Infection Models.
    Wang W; Bao X; Bové M; Rigole P; Meng X; Su J; Coenye T
    Microbiol Spectr; 2022 Oct; 10(5):e0169622. PubMed ID: 36194139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis.
    Di Bonaventura G; Lupetti V; Di Giulio A; Muzzi M; Piccirilli A; Cariani L; Pompilio A
    Microbiol Spectr; 2023 Aug; 11(4):e0035223. PubMed ID: 37306577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms.
    Orazi G; Jean-Pierre F; O'Toole GA
    J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
    Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of polymyxin B-doxycycline in combination against Pseudomonas aeruginosa in vitro and in a mouse model of acute pneumonia.
    Gaurav A; Kothari A; Omar BJ; Pathania R
    Int J Antimicrob Agents; 2020 Jul; 56(1):106022. PubMed ID: 32439481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.
    Maisetta G; Grassi L; Esin S; Serra I; Scorciapino MA; Rinaldi AC; Batoni G
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926942
    [No Abstract]   [Full Text] [Related]  

  • 14. Small Molecule IITR00693 (2-Aminoperimidine) Synergizes Polymyxin B Activity against
    Saini M; Gaurav A; Kothari A; Omar BJ; Gupta V; Bhattacharjee A; Pathania R
    ACS Infect Dis; 2023 Mar; 9(3):692-705. PubMed ID: 36716174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Fresh Shine onCystic Fibrosis Inhalation Therapy: Antimicrobial Synergy of Polymyxin B in Combination with Silver Nanoparticles.
    Jasim R; Schneider EK; Han M; Azad MAK; Hussein M; Nowell C; Baker MA; Wang J; Li J; Velkov T
    J Biomed Nanotechnol; 2017 Apr; 13(4):447-57. PubMed ID: 29384621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous Alginate Protects Staphylococcus aureus from Killing by Pseudomonas aeruginosa.
    Price CE; Brown DG; Limoli DH; Phelan VV; O'Toole GA
    J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 31792010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.
    Wieneke MK; Dach F; Neumann C; Görlich D; Kaese L; Thißen T; Dübbers A; Kessler C; Große-Onnebrink J; Küster P; Schültingkemper H; Schwartbeck B; Roth J; Nofer JR; Treffon J; Posdorfer J; Boecken JM; Strake M; Abdo M; Westhues S; Kahl BC
    mSphere; 2021 Jun; 6(3):e0035821. PubMed ID: 34160233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pseudomonas aeruginosa Antimicrobial Affects the Biogeography but Not Fitness of Staphylococcus aureus during Coculture.
    Barraza JP; Whiteley M
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785630
    [No Abstract]   [Full Text] [Related]  

  • 19. Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
    Feizi S; Cooksley CM; Nepal R; Psaltis AJ; Wormald PJ; Vreugde S
    Pathology; 2022 Jun; 54(4):453-459. PubMed ID: 34844745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
    Sanchez CJ; Akers KS; Romano DR; Woodbury RL; Hardy SK; Murray CK; Wenke JC
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4353-61. PubMed ID: 24841260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.